Revolution Medicines, Inc.
RVMD
Rankning i aktier
#587
Revolution Medicines, Inc. is a precision oncology firm operating in the... Revolution Medicines, Inc. is a precision oncology firm operating in the clinical development stage, dedicated to creating innovative treatments that target novel pathways crucial for RAS-driven cancers. Its pipeline includes several promising drug candidates: RMC-4630, an SHP2 inhibitor, is currently undergoing Phase 1/2 clinical trials for various solid tumors, such as gynecological and colorectal cancers. The company's portfolio also features RMC-5845, a selective inhibitor designed to target SOS1, a protein responsible for activating RAS within cells, and RMC-5552, a highly selective inhibitor for hyperactive mTORC1 signaling found in cancerous cells. Further expanding its therapeutic arsenal, Revolution Medicines is advancing RMC-6291, which selectively inhibits mutated forms of KRASG12C(ON) and NRASG12C(ON). Another promising compound, RMC-6236, specifically targets and inhibits a range of active RAS(ON) variants. Its research efforts also encompass other active RAS inhibitors aimed at KRASG13C(ON) and KRASG12D(ON) mutations. Revolution Medicines has established a collaborative partnership with Sanofi to research and develop SHP2 inhibitors, a collaboration that includes the development of RMC-4630. Established in 2014, Revolution Medicines, Inc. operates from its corporate headquarters situated in Redwood City, California.
Aktiekurs
$186.44
Marknadsvärde
$39.96B
Förändring (1 dag)
-4.04%
Förändring (1 år)
251.90%
Land
US
Handel Revolution Medicines, Inc. (RVMD)
Kategori
Healthcare
Aktiekurshistorik för Revolution Medicines, Inc. (RVMD)
Högsta slutkurs: $193.84 den 2026-10-01
Lägsta slutkurs: $30.68 den 2020-02-01
Lägsta slutkurs: $30.68 den 2020-02-01
Aktiekurshistorik för Revolution Medicines, Inc. från 2020 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | 73.04% |
| 2025 | 72.22% |
| 2024 | 75.37% |
| 2023 | 10.12% |
| 2022 | -8.93% |
| 2021 | -38.16% |
| 2020 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $536.36 | 25.78% |
US
|
|
| $231.06 | 760.55% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $879.87 | 8.07% |
NL
|
|
| $289.51 | 1.72% |
BE
|
